Both in Biotechnology
Bio-Techne vs ImmunityBio
Over the past year TECH returned +16.1% and IBRX returned +245.4%; their daily moves had a correlation of -0.00.
TECH +16.1% IBRX +245.4%Growth of $1, one year, split-adjusted
| Metric | TECH | IBRX |
|---|---|---|
| Price | $72.66 | $8.29 |
| Market cap | $11.41B | $8.79B |
| Today | −0.07% | −5.15% |
| 1 month | +0.4% | −10.7% |
| 6 months | +32.1% | +16.6% |
| Year to date | +23.6% | +318.7% |
| 1 year | +17.2% | +242.6% |
| Revenue growth (YoY) | +1.3% | +93.9% |
| Gross margin | 65.8% | 99.4% |
| Net margin | 17.0% | −449.6% |
| P/E (TTM) | 62.7× | — |
| Price / sales | 9.4× | 53.0× |
| Net cash | $64.7M | -$57.7M |
| Dividend yield | 0.44% | — |
| Volatility (60d) | 2.5% | 68.0% |
| Short % of float | 4.9% | 31.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).